Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Brain Neoplasms 2 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Glioma 1 Glioblastoma 1

Interventions

Temozolomide 41 Magnetic Resonance Spectroscopy 21 Radiotherapy 19 Specimen Handling 15 Radiation 12 Bevacizumab 11 Lomustine 9 pembrolizumab 6 fludarabine 5 Surgical Procedures, Operative 5 atezolizumab 4 Nivolumab 4 Ipilimumab 4 Cyclophosphamide 4 Carboplatin 4 Biopsy 4 cemiplimab 3 azeliragon 3 Immunoglobulin G 3 Disulfides 3 Aminolevulinic Acid 3 veliparib 2 trametinib 2 rocakinogene sifuplasmid 2 ribociclib 2 poly ICLC 2 pamiparib 2 olaparib 2 niraparib 2 lutetium Lu 177 dotatate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × fluciclovine F-18 × 90 days × Clear all

NCT06319027 2026-05-15

GABLE

Eastern Cooperative Oncology Group

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡